How we manufacture, in our own Canadian laboratory
Production, extraction, purification and analytical control all run in the same laboratory in Guelph, Ontario, under one team. The process details stay ours. What follows is what that platform means for the material you receive.
A fermentation and extraction platform built in-house
TripleBond Scientific has developed proprietary fermentation, extraction and purification technologies that support efficient, repeatable mycotoxin production. These are our own methods, and the yields they give are the reason a compact laboratory can quote gram and kilogram-scale projects rather than stopping at analytical vials.
Fermentation developed in-house
Our own biological production methods give high, repeatable yields from a small manufacturing footprint.
Fully contained production
Cultures are grown in sealed, filtered vessels from inoculation through harvest. Spores and toxin-bearing material remain contained throughout, protecting operators and preventing cross-contamination between batches.
Self-designed extraction platform
An in-house engineered extraction system supports repeatable crude processing while reducing operator exposure.
Purification and release under one roof
Extraction, purification and analytical review are coordinated internally, so every batch stays under our control from production through release.
Containment and quality framework
The laboratory operates under Containment Level 2 as approved by the Public Health Agency of Canada (PHAC), and under Plant Pest Containment Level 1 (PPC-1) conditions approved by the Canadian Food Inspection Agency (CFIA), which supports work with regulated agricultural strains. Quality management is ISO 9001:2015 controlled.
Containment is not only a regulatory formality for this material. Mycotoxin-producing cultures and purified toxins both need to stay where they are put — for the people working with them, and so that one batch cannot contaminate the next. That is designed into the production route rather than added at the end.
Why manufacturing it ourselves changes what you get
Much of the mycotoxin standards market is distribution: material is bought in, relabelled and resold. TripleBond makes what it sells, in Canada. Three practical consequences follow.
- Direct-manufacturer pricing. There is no distribution margin stacked on top of a production cost.
- Consistent batches. The same platform, the same team and the same release review produce each batch, rather than whatever a supply chain happened to source.
- A scientist to talk to. Technical and commercial communication is with the people who make the material, which matters most when something about your application is unusual.
It also means supply is not dependent on another manufacturer's priorities. For customers who need the same material repeatedly — diagnostic kit production, multi-year trial programmes — that continuity is usually the deciding factor.
Common questions
Where are TripleBond's mycotoxins made?
In TripleBond's own laboratory in Guelph, Ontario, Canada. The material is manufactured there rather than sourced from another producer and resold.
What containment does the facility operate under?
Containment Level 2 as approved by the Public Health Agency of Canada (PHAC), and Plant Pest Containment Level 1 conditions approved by the Canadian Food Inspection Agency (CFIA). Quality management is ISO 9001:2015 controlled.
How are mycotoxins produced?
By fermentation, using production methods developed in-house, followed by extraction on a self-designed extraction platform and purification and analytical release within the same laboratory. The detailed process is proprietary.
Does TripleBond resell material made by other manufacturers?
No. The compounds in the catalogue are produced in our own Canadian laboratory.
See what we make
The catalogue lists the mycotoxin reference standards produced on this platform, with published prices for analytical quantities.
Browse the catalogue